98-7982. Implantation or Injectable Dosage Form New Animal Drugs; Tilmicosin Phosphate Injection; Correction

[Federal Register Volume 63, Number 59 (Friday, March 27, 1998)]
[Rules and Regulations]
[Page 14818]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-7982]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 522


Implantation or Injectable Dosage Form New Animal Drugs; 
Tilmicosin Phosphate Injection; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule that appeared in the Federal Register of February 17, 1998 (63 FR 
7701). The document amended the drug regulations to reflect approval of 
a supplemental new animal drug application filed by Elanco Animal 
Health, A Division of Eli Lilly and Co. The document was published with 
an error. This document corrects that error.

EFFECTIVE DATE: February 17, 1998.

FOR FURTHER INFORMATION CONTACT: LaJuana D. Caldwell, Office of Policy 
(HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 
20857, 301-443-2994.

     In FR Doc. 98-3897, appearing on page 7701, in the Federal 
Register of Tuesday, February 17, 1998, the following correction is 
made:


Sec. 522.2471  [Corrected]

    1. On page 7701, in the third column, in amendment no. 2, in line 
four, ``13th and 14th'' is corrected to read ``14th and 15th''.

    Dated: March 19, 1998.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 98-7982 Filed 3-26-98; 8:45 am]
BILLING CODE 4160-01-F